Chelation therapy (or chemical
endarterectomy) is considered an unproven therapeutic modality for
the treatment of the following conditions, and is not covered:
• Multiple Sclerosis (MS).
• Arthritis.
• Hypoglycemia.
• Diabetes.
• Arteriosclerosis.
• Malaria.
• Cancer.
• Alzheimer’s disease.
• Autism Spectrum Disorders (ASD).
• Other off-label uses of FDA
approved chelating agents.